Issue 3 - August 2014
Timothy Yap and the ComPAKT team put their study in the spotlight sharing experience of leading a CA study.
CA Clinical Trial Co-ordinator's workshop
Cathy McDowell writes about the recent engagement with the clinical trial co-ordinator's at a workshop held at the Angel Building.
Hazel Jones shares her thoughts on the impact of the new Preclinical Grant scheme via the NAC.
Expression of Interest Calls repsonses
Response to our 2014 EOI calls involving compounds from Lilly, Astex, AstraZeneca and Medimmune.
There is a growing portfolio of studies and more in the pipeline from the recent Astex EOI.
It's all in the name: Kate Hardstaff
Kate Hardstaff talks about the name chance of CRUK's new Centre for Drug Development and the upcoming NCRI Conference.